The correlation between CCND1 expression levels and cellular proliferation in breast cancer cells has been also confirmed by CCND1 silencing experiments, indicating cyclin D1 as a potential therapeutic target for breast cancer [26, 27]. Here, CCND1 is linked to breast cancer.